scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.FREERADBIOMED.2009.02.011 |
P698 | PubMed publication ID | 19248829 |
P2093 | author name string | Jose E Tanus-Santos | |
Lusiane M Bendhack | |||
Raquel F Gerlach | |||
Elen Rizzi | |||
Michele M Castro | |||
Gerson J Rodrigues | |||
Carla S Ceron | |||
P433 | issue | 9 | |
P304 | page(s) | 1298-1307 | |
P577 | publication date | 2009-02-25 | |
P1433 | published in | Free Radical Biology and Medicine | Q5500023 |
P1476 | title | Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension | |
P478 | volume | 46 |
Q82350588 | Albumin modulates the production of matrix metalloproteinases-2 and -9 in podocytes |
Q39211841 | Anti-proliferative and matrix metalloproteinase-2 inhibition of Longkong (Lansium domesticum) extracts on human mouth epidermal carcinoma |
Q44784670 | Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension. |
Q34154805 | Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia |
Q43538572 | Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR. |
Q84060784 | Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism |
Q43271695 | Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. |
Q36042695 | Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension |
Q37393748 | Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension. |
Q36303153 | Biochemical changes induced by grape seed extract and low level laser therapy administration during intraoral wound healing in rat liver: an experimental and in silico study |
Q37477458 | Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments |
Q55385725 | Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding. |
Q83393091 | Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients |
Q82353105 | Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension |
Q35818344 | Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension |
Q33892142 | Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats |
Q89697823 | Early Programming of Adult Systemic Essential Hypertension |
Q33834911 | Effects of Baicalin on Blood Pressure and Left Ventricular Remodeling in Rats with Renovascular Hypertension |
Q58580785 | Effects of a 12-week aerobic exercise on markers of hypertension in men |
Q45774346 | Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells |
Q24595411 | Effects of tempol and redox-cycling nitroxides in models of oxidative stress |
Q36640681 | Elevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer |
Q54335066 | Ethanol consumption increases the expression of endothelial nitric oxide synthase, inducible nitric oxide synthase and metalloproteinases in the rat kidney. |
Q36194043 | Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis |
Q87422854 | Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress |
Q44391648 | Experimental and clinical findings regarding matrix metalloproteinases in cardiovascular diseases |
Q26864722 | Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target |
Q42730357 | In vivo prevention of bladder urotoxicity: purified hydroxytyrosol ameliorates urotoxic effects of cyclophosphamide and buthionine sulfoximine in mice |
Q35056901 | Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases |
Q58559602 | Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension |
Q36009930 | Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease |
Q90366733 | Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction |
Q84773115 | Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children |
Q34505861 | Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment |
Q37962503 | Matrix metalloproteinases and small artery remodeling |
Q38224193 | Matrix metalloproteinases are involved in cardiovascular diseases |
Q36644577 | Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins |
Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
Q27026468 | Mechanisms of the inward remodeling process in resistance vessels: is the actin cytoskeleton involved? |
Q38713934 | Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in L-NAME-induced hypertensive rats |
Q37738029 | Oxidative stress and hypertension: current concepts |
Q92850623 | Oxidative stress and vascular stiffness in hypertension: A renewed interest for antioxidant therapies? |
Q36645351 | Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats. |
Q35216484 | Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension |
Q49163184 | Radical Scavenger Capacity of Jabuticaba Fruit (Myrciaria cauliflora) and Its Biological Effects in Hypertensive Rats. |
Q88467577 | Relationship between inducible NOS single-nucleotide polymorphisms and hypertension in Han Chinese |
Q51471526 | Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet. |
Q53261742 | Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin. |
Q33812756 | Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. |
Q33999929 | Study of the correlations among some parameters of the oxidative status, gelatinases, and their inhibitors in a group of subjects with metabolic syndrome |
Q42679423 | Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1. |
Q43915235 | Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy |
Q37254427 | Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension |
Q34311404 | Tempol, a superoxide dismutase mimetic, prevents cerebral vessel remodeling in hypertensive rats |
Q50501810 | Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. |
Q64933327 | The effect of resveratrol on expression of matrix metalloproteinase 9 and its tissue inhibitors in vascular smooth muscle cells. |
Q41808888 | The oxygen free radicals control MMP-9 and transcription factors expression in the spontaneously hypertensive rat. |
Q34836065 | The role of reactive oxygen species in microvascular remodeling |
Q47734987 | Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease |
Q48729036 | Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5. |
Q34302541 | Vascular wall extracellular matrix proteins and vascular diseases |
Search more.